ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
페노바르비탈 시장 규모는 최근 꾸준히 성장하고 있습니다. 2025년 15억 4,000만 달러에서 2026년에는 16억 2,000만 달러에 이르고, CAGR 4.9%의 성장이 전망됩니다. 지난 몇 년간 임상적 유효성, 필수 의약품 목록에 광범위하게 등재된 점, 높은 간질 유병률, 신생아 치료에서의 사용, 신약에 비해 저렴한 가격 등이 성장에 기여한 것으로 보입니다.
페노바르비탈 시장 규모는 향후 몇 년간도 꾸준한 성장이 전망됩니다. 2030년에는 19억 6,000만 달러에 이르고, CAGR은 5.0%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 자원이 한정된 환경에서의 지속적인 수요, 제네릭 의약품 생산 확대, 신생아 중환자실 증가, 간질 진단율 증가, 필수 의약품에 대한 접근성 강화 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 간질 및 신생아 경련 관리에 대한 지속적인 사용, 제네릭 페노바르비탈의 가용성 향상, 비용 효율적인 항경련제에 대한 관심 증가, 병원 기반 경련 관리 확대, 장기적인 약물 안전성 모니터링 증가 등이 있습니다. 등을 꼽을 수 있습니다.
간질 유병률 증가는 향후 몇 년 동안 페노바르비탈 시장의 성장을 견인할 것으로 예측됩니다. 간질은 뇌의 비정상적인 전기적 활동으로 인한 반복적인 유발 요인이 없는 발작이 특징인 신경질환입니다. 유병률 증가는 주로 인지도가 높아져 더 많은 사람들이 증상을 인식하고 의료적 평가를 요청하면서 보고된 사례 수가 증가했기 때문입니다. 페노바르비탈은 항경련제로서 뇌의 신경 활동을 억제하여 발작 예방 및 조절에 효과가 있습니다. 예를 들어, 2024년 2월 스위스에 본부를 둔 국제 공중보건기구인 세계보건기구(WHO)는 전 세계적으로 약 5,000만 명이 간질을 앓고 있다고 보고해 세계에서 가장 흔한 신경질환 중 하나임을 확인했습니다. 따라서 간질 유병률 증가는 페노바르비탈 시장의 확대를 뒷받침할 것으로 예측됩니다.
페노바르비탈 시장에서 사업을 전개하는 주요 기업들은 치료 효과와 안전성 향상을 목표로 페노바르비탈 나트륨과 같은 혁신적인 제제 개발에 주력하고 있습니다. 페노바르비탈 나트륨은 페노바르비탈의 나트륨 염 형태이며, 주로 항경련제 및 진정제로 사용됩니다. 특히 간질 발작 관리, 불안 및 불면증 치료, 의료 시술 전 진정 유도에 널리 처방되고 있습니다. 예를 들어, 2023년 1월, 인도에 본사를 둔 제약사 Sun Pharmaceutical Industries는 미국에서 SEZABY(페노바르비탈 나트륨)를 출시했습니다. 이 약은 만삭아 및 미숙아 신생아의 발작 치료를 위해 FDA가 승인한 최초이자 유일한 의약품입니다. 이 제제는 벤질 알코올과 프로파일렌 글리콜을 함유하지 않아 신생아에게 사용하기에 더 안전합니다. SEZABY는 희귀의약품으로 지정되어 있으며, 신생아 경련 억제에 효과적이라는 임상 데이터를 통해 입증된 바 있습니다. 이는 취약한 환자군의 중요한 미충족 수요에 대응하기 위한 것입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Phenobarbital is a long-acting barbiturate medication primarily used to control and prevent seizures, especially in the treatment of epilepsy. It is also occasionally prescribed as a sedative for anxiety or to manage withdrawal symptoms. The drug enhances the effects of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits nerve activity in the brain, producing a calming effect on the central nervous system and reducing the likelihood of seizures.
The main indications for phenobarbital are epilepsy and neonatal seizures. Epilepsy is a neurological disorder marked by recurrent, unprovoked seizures. Phenobarbital is available in various dosage forms, including tablets, capsules, and injectables, and is distributed through hospital pharmacies, retail pharmacies, and online pharmacies. It is used in seizure management, anesthesia, sleep disorders, and alcohol withdrawal syndrome, serving a range of end users such as hospitals, clinics, research laboratories, and homecare settings.
Tariffs have influenced the phenobarbital market by increasing the cost of imported active pharmaceutical ingredients and synthesis intermediates used in drug manufacturing. These impacts are most evident in generic drug manufacturing regions across Asia Pacific and Latin America, where producers rely on cross border sourcing for essential inputs. Rising tariff related expenses have increased overall production costs and pressured pricing strategies for antiepileptic drugs. This has influenced procurement planning and supply availability in both public and private healthcare channels. However, tariffs have encouraged domestic API production, expanded local manufacturing capacity, and improved long term supply security.
The phenobarbital market research report is one of a series of new reports from The Business Research Company that provides phenobarbital market statistics, including phenobarbital industry global market size, regional shares, competitors with a phenobarbital market share, detailed phenobarbital market segments, market trends and opportunities, and any further data you may need to thrive in the phenobarbital industry. This phenobarbital market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The phenobarbital market size has grown steadily in recent years. It will grow from $1.54 billion in 2025 to $1.62 billion in 2026 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to long-standing clinical efficacy, widespread availability in essential medicine lists, high prevalence of epilepsy, use in neonatal care, affordability compared to newer drugs.
The phenobarbital market size is expected to see steady growth in the next few years. It will grow to $1.96 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to continued demand in low-resource settings, expansion of generic manufacturing, growth in neonatal intensive care units, rising epilepsy diagnosis rates, focus on essential medicines access. Major trends in the forecast period include continued use in epilepsy and neonatal seizure management, increasing availability of generic phenobarbital, growing focus on cost-effective anticonvulsant therapies, expansion of hospital-based seizure management, rising monitoring of long-term drug safety.
The rising prevalence of epilepsy is expected to drive the growth of the phenobarbital market in the coming years. Epilepsy is a neurological disorder marked by recurrent, unprovoked seizures resulting from abnormal electrical activity in the brain. The increasing prevalence is largely due to greater awareness, as more individuals recognize symptoms and seek medical evaluation, leading to higher reported cases. Phenobarbital is effective in managing epilepsy as an anticonvulsant medication that slows neuronal activity in the brain, helping to prevent and control seizures. For example, in February 2024, the World Health Organization, a Switzerland-based international public health agency, reported that approximately 50 million people worldwide were living with epilepsy, confirming its status as one of the most common neurological disorders globally. Consequently, the growing prevalence of epilepsy is expected to support the expansion of the phenobarbital market.
Major companies operating in the phenobarbital market are focusing on developing innovative formulations, such as phenobarbital sodium, to enhance treatment efficacy and safety. Phenobarbital sodium is the sodium salt form of phenobarbital, primarily used as an anticonvulsant and sedative. It is commonly prescribed to manage seizures, particularly in epilepsy, as well as to treat anxiety, insomnia, and occasionally to induce sedation before medical procedures. For instance, in January 2023, Sun Pharmaceutical Industries Ltd., an India-based pharmaceutical company, launched SEZABY (phenobarbital sodium) in the U.S., the first and only FDA-approved medication specifically indicated for treating seizures in both term and preterm neonates. This formulation is free from benzyl alcohol and propylene glycol, making it safer for use in newborns. SEZABY received orphan drug designation and is supported by clinical data demonstrating its effectiveness in controlling neonatal seizures, addressing a critical unmet need in this vulnerable patient population.
In September 2023, Pharmanovia Limited, a UK-based healthcare lifecycle management company, acquired the central nervous system (CNS) portfolio of Sanofi S.A. for an undisclosed amount. Through this acquisition, Pharmanovia aims to strengthen and expand its neurology/CNS franchise by pursuing market growth and product diversification, while leveraging its lifecycle-management expertise to maintain and advance established CNS therapies. Sanofi S.A. is a France-based healthcare company specializing in the research, development, and commercialization of prescription medicines and vaccines worldwide.
Major companies operating in the phenobarbital market are Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, Fresenius Kabi AG, Baxter International Inc., Par Pharmaceutical Inc., Harman Finochem Ltd., Manus Aktteva Biopharma LLP, Shandong Xinhua Pharmaceutical Co. Ltd., Alkaloida Chemical Company Zrt., Yashiro Pharmaceutical Co. Ltd., JPN Pharma Pvt. Ltd., Pfizer CentreOne, Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Zydus Lifesciences Ltd., Aurobindo Pharma Ltd.
North America was the largest region in the phenobarbital market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the phenobarbital market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the phenobarbital market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The phenobarbital market consists of sales of products including phenobarbital tablets, phenobarbital oral elixir, phenobarbital injectables, veterinary phenobarbital products, and combination medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Phenobarbital Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses phenobarbital market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for phenobarbital ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The phenobarbital market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Indication: Epilepsy; Neonatal Seizures
2) By Dosage Forms: Tablets; Capsules; Injectables
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Continued Use In Epilepsy And Neonatal Seizure Management
4.2.2 Increasing Availability Of Generic Phenobarbital
4.2.3 Growing Focus On Cost-Effective Anticonvulsant Therapies
4.2.4 Expansion Of Hospital-Based Seizure Management
4.2.5 Rising Monitoring Of Long-Term Drug Safety
5. Phenobarbital Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Clinics
5.3 Research Laboratories
5.4 Homecare Settings
5.5 Neurology Centers
6. Phenobarbital Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Phenobarbital Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Phenobarbital PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Phenobarbital Market Size, Comparisons And Growth Rate Analysis
7.3. Global Phenobarbital Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Phenobarbital Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Phenobarbital Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Phenobarbital Market Segmentation
9.1. Global Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Epilepsy, Neonatal Seizures
9.2. Global Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Tablets, Capsules, Injectables
9.3. Global Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10. Phenobarbital Market Regional And Country Analysis
10.1. Global Phenobarbital Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Phenobarbital Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Phenobarbital Market
11.1. Asia-Pacific Phenobarbital Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Phenobarbital Market
12.1. China Phenobarbital Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Phenobarbital Market
13.1. India Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Phenobarbital Market
14.1. Japan Phenobarbital Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Phenobarbital Market
15.1. Australia Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Phenobarbital Market
16.1. Indonesia Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Phenobarbital Market
17.1. South Korea Phenobarbital Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Phenobarbital Market
18.1. Taiwan Phenobarbital Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Phenobarbital Market
19.1. South East Asia Phenobarbital Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Phenobarbital Market
20.1. Western Europe Phenobarbital Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Phenobarbital Market
21.1. UK Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Phenobarbital Market
22.1. Germany Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Phenobarbital Market
23.1. France Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Phenobarbital Market
24.1. Italy Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Phenobarbital Market
25.1. Spain Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Phenobarbital Market
26.1. Eastern Europe Phenobarbital Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Phenobarbital Market
27.1. Russia Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Phenobarbital Market
28.1. North America Phenobarbital Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Phenobarbital Market
29.1. USA Phenobarbital Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Phenobarbital Market
30.1. Canada Phenobarbital Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Phenobarbital Market
31.1. South America Phenobarbital Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Phenobarbital Market
32.1. Brazil Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Phenobarbital Market
33.1. Middle East Phenobarbital Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Phenobarbital Market
34.1. Africa Phenobarbital Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Phenobarbital Market, Segmentation By Indication, Segmentation By Dosage Forms, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Phenobarbital Market Regulatory and Investment Landscape
36. Phenobarbital Market Competitive Landscape And Company Profiles
36.1. Phenobarbital Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Phenobarbital Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Phenobarbital Market Company Profiles
36.3.1. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Sandoz Group AG Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Hikma Pharmaceuticals PLC Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
37. Phenobarbital Market Other Major And Innovative Companies
Lupin Limited, Fresenius Kabi AG, Baxter International Inc., Par Pharmaceutical Inc., Harman Finochem Ltd., Manus Aktteva Biopharma LLP, Shandong Xinhua Pharmaceutical Co. Ltd., Alkaloida Chemical Company Zrt., Yashiro Pharmaceutical Co. Ltd., JPN Pharma Pvt. Ltd., Pfizer CentreOne, Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Zydus Lifesciences Ltd., Aurobindo Pharma Ltd.
38. Global Phenobarbital Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Phenobarbital Market
40. Phenobarbital Market High Potential Countries, Segments and Strategies
40.1 Phenobarbital Market In 2030 - Countries Offering Most New Opportunities
40.2 Phenobarbital Market In 2030 - Segments Offering Most New Opportunities
40.3 Phenobarbital Market In 2030 - Growth Strategies
